State-of-the-art genomics approaches in toxicology

Mutation Research - Reviews in Mutation Research

Volumn 705, Issue 3, 2010, Pages 165-171

  Van Hummelen, Paul ^a,b   Sasaki, Jennifer ^c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b RUTGERS UNIVERSITY   (United States)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Genomics; Microarrays; Toxicogenomics; Toxicology; Transcriptomics

Indexed keywords

CARCINOGEN; PARACETAMOL; PARAQUAT;

DRUG DEVELOPMENT; DRUG SCREENING; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOTOXICITY; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; TOXICOGENETICS; TRANSCRIPTOMICS;

ANIMALS; BIOLOGICAL MARKERS; CARCINOGENS; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; TECHNOLOGY, PHARMACEUTICAL; TOXICOGENETICS; TOXICOLOGY;

EID: 78649328673     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2010.04.007     Document Type: Review

References (43)

1. Kola I., Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat. Rev. Drug Discov. 2004, 3:711-715.
2. Barros S.A., Martin R.B. Predictive toxicogenomics in preclinical discovery. Methods Mol. Biol. 2008, 460:89-112.
3. Dambach D.M., Andrews B.A., Moulin F. New technologies and screening strategies for hepatotoxicity: use of in vitro models. Toxicol. Pathol. 2005, 33:17-26.
4. Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat. Rev. Drug Discov. 2005, 4:489-499.
5. Heinloth A.N., Irwin R.D., Boorman G.A., Nettesheim P., Fannin R.D., Sieber S.O., Snell M.L., Tucker C.J., Li L., Travlos G.S., Vansant G., Blackshear P.E., Tennant R.W., Cunningham M.L., Paules R.S. Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol. Sci. 2004, 80:193-202.
6. McMillian M., Nie A.Y., Parker J.B., Leone A., Bryant S., Kemmerer M., Herlich J., Liu Y., Yieh L., Bittner A., Liu X., Wan J., Johnson M.D. A gene expression signature for oxidant stress/reactive metabolites in rat liver. Biochem. Pharmacol. 2004, 68:2249-2261.
7. Auman J.T., Chou J., Gerrish K., Huang Q., Jayadev S., Blanchard K., Paules R.S. Identification of genes implicated in methapyrilene-induced hepatotoxicity by comparing differential gene expression in target and nontarget tissue. Environ. Health Perspect. 2007, 115:572-578.
8. Kulkarni K., Larsen P., Linninger A.A. Assessing chronic liver toxicity based on relative gene expression data. J. Theor. Biol. 2008, 254:308-318.
9. Lobenhofer E.K., Auman J.T., Blackshear P.E., Boorman G.A., Bushel P.R., Cunningham M.L., Fostel J.M., Gerrish K., Heinloth A.N., Irwin R.D., Malarkey D.E., Merrick B.A., Sieber S.O., Tucker C.J., Ward S.M., Wilson R.E., Hurban P., Tennant R.W., Paules R.S. Gene expression response in target organ and whole blood varies as a function of target organ injury phenotype. Genome Biol. 2008, 9:R100.
10. Heinloth A.N., Boorman G.A., Foley J.F., Flagler N.D., Paules R.S. Gene expression analysis offers unique advantages to histopathology in liver biopsy evaluations. Toxicol. Pathol. 2007, 35:276-283.
11. Boess F., Durr E., Schaub N., Haiker M., Albertini S., Suter L. An in vitro study on 5-HT6 receptor antagonist induced hepatotoxicity based on biochemical assays and toxicogenomics. Toxicol. In Vitro 2007, 21:1276-1286.
12. Le Fevre A.C., Boitier E., Marchandeau J.P., Sarasin A., Thybaud V. Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling. Mutat. Res. 2007, 619:16-29.
13. Nie A.Y., McMillian M., Parker J.B., Leone A., Bryant S., Yieh L., Bittner A., Nelson J., Carmen A., Wan J., Lord P.G. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity. Mol. Carcinog. 2006, 45:914-933.
14. Fielden M.R., Brennan R., Gollub J. A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. Toxicol. Sci. 2007, 99:90-100.
15. Fielden M.R., Nie A., McMillian M., Elangbam C.S., Trela B.A., Yang Y., Dunn R.T., Dragan Y., Fransson-Stehen R., Bogdanffy M., Adams S.P., Foster W.R., Chen S.J., Rossi P., Kasper P., Jacobson-Kram D., Tatsuoka K.S., Wier P.J., Gollub J., Halbert D.N., Roter A., Young J.K., Sina J.F., Marlowe J., Martus H.J., Aubrecht J., Olaharski A.J., Roome N., Nioi P., Pardo I., Snyder R., Perry R., Lord P., Mattes W., Car B.D. Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the rat. Toxicol. Sci. 2008, 103:28-34.
16. Beyer R.P., Fry R.C., Lasarev M.R., McConnachie L.A., Meira L.B., Palmer V.S., Powell C.L., Ross P.K., Bammler T.K., Bradford B.U., Cranson A.B., Cunningham M.L., Fannin R.D., Higgins G.M., Hurban P., Kayton R.J., Kerr K.F., Kosyk O., Lobenhofer E.K., Sieber S.O., Vliet P.A., Weis B.K., Wolfinger R., Woods C.G., Freedman J.H., Linney E., Kaufmann W.K., Kavanagh T.J., Paules R.S., Rusyn I., Samson L.D., Spencer P.S., Suk W., Tennant R.J., Zarbl H. Multicenter study of acetaminophen hepatotoxicity reveals the importance of biological endpoints in genomic analyses. Toxicol. Sci. 2007, 99:326-337.
17. Wang X., Zaidi A., Pal R., Garrett A.S., Braceras R., Chen X.W., Michaelis M.L., Michaelis E.K. Genomic and biochemical approaches in the discovery of mechanisms for selective neuronal vulnerability to oxidative stress. BMC Neurosci. 2009, 10:12.
18. Koncarevic S., Urig S., Steiner K., Rahlfs S., Herold-Mende C., Sueltmann H., Becker K. Differential genomic and proteomic profiling of glioblastoma cells exposed to terpyridineplatinum(II) complexes. Free Radic. Biol. Med. 2009, 46:1096-1108.
19. Amin R.P., Vickers A.E., Sistare F., Thompson K.L., Roman R.J., Lawton M., Kramer J., Hamadeh H.K., Collins J., Grissom S., Bennett L., Tucker C.J., Wild S., Kind C., Oreffo V., Davis J.W., Curtiss S., Naciff J.M., Cunningham M., Tennant R., Stevens J., Car B., Bertram T.A., Afshari C.A. Identification of putative gene based markers of renal toxicity. Environ. Health Perspect. 2004, 112:465-479.
20. Ellinger-Ziegelbauer H., Stuart B., Wahle B., Bomann W., Ahr H.J. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat. Res. 2005, 575:61-84.
21. van Delft J.H., van A.E., van Breda S.G., Herwijnen M.H., Staal Y.C., Kleinjans J.C. Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling. Mutat. Res. 2005, 575:17-33.
22. Henderson L., Albertini S., Aardema M. Thresholds in genotoxicity responses. Mutat. Res. 2000, 464:123-128.
23. Amundson S.A., Do K.T., Vinikoor L., Koch-Paiz C.A., Bittner M.L., Trent J.M., Meltzer P., Fornace A.J. Stress-specific signatures: expression profiling of p53 wild-type and -null human cells. Oncogene 2005, 24:4572-4579.
24. Dahlquist K.D., Salomonis N., Vranizan K., Lawlor S.C., Conklin B.R. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat. Genet. 2002, 31:19-20.
25. Doniger S.W., Salomonis N., Dahlquist K.D., Vranizan K., Lawlor S.C., Conklin B.R. MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol. 2003, 4:R7.
26. Yu X., Griffith W.C., Hanspers K., Dillman J.F., Ong H., Vredevoogd M.A., Faustman E.M. A system-based approach to interpret dose- and time-dependent microarray data: quantitative integration of gene ontology analysis for risk assessment. Toxicol. Sci. 2006, 92:560-577.
27. Liu K., Lehmann K.P., Sar M., Young S.S., Gaido K.W. Gene expression profiling following in utero exposure to phthalate esters reveals new gene targets in the etiology of testicular dysgenesis. Biol. Reprod. 2005, 73:180-192.
28. Yu X., Robinson J.F., Gribble E., Hong S.W., Sidhu J.S., Faustman E.M. Gene expression profiling analysis reveals arsenic-induced cell cycle arrest and apoptosis in p53-proficient and p53-deficient cells through differential gene pathways. Toxicol. Appl. Pharmacol. 2008, 233:389-403.
29. Tong W., Cao X., Harris S., Sun H., Fang H., Fuscoe J., Harris A., Hong H., Xie Q., Perkins R., Shi L., Casciano D. ArrayTrack-supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ. Health Perspect. 2003, 111:1819-1826.
30. Liu J., Xie Y., Ducharme D.M., Shen J., Diwan B.A., Merrick B.A., Grissom S.F., Tucker C.J., Paules R.S., Tennant R., Waalkes M.P. Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure. Environ. Health Perspect. 2006, 114:404-411.
31. Mayburd A.L., Martlinez A., Sackett D., Liu H., Shih J., Tauler J., Avis I., Mulshine J.L. Ingenuity network-assisted transcription profiling: identification of a new pharmacologic mechanism for MK886. Clin. Cancer Res. 2006, 12:1820-1827.
32. Nikitin A., Egorov S., Daraselia N., Mazo I. Pathway studio-the analysis and navigation of molecular networks. Bioinformatics 2003, 19:2155-2157.
33. Yuryev A., Mulyukov Z., Kotelnikova E., Maslov S., Egorov S., Nikitin A., Daraselia N., Mazo I. Automatic pathway building in biological association networks. BMC Bioinform. 2006, 7:171.
34. Nikolsky Y., Ekins S., Nikolskaya T., Bugrim A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol. Lett. 2005, 158:20-29.
35. Xu E.Y., Perlina A., Vu H., Troth S.P., Brennan R.J., Aslamkhan A.G., Xu Q. Integrated pathway analysis of rat urine metabolic profiles and kidney transcriptomic profiles to elucidate the systems toxicology of model nephrotoxicants. Chem. Res. Toxicol. 2008, 21:1548-1561.
36. Huang d.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
37. Khatri P., Sellamuthu S., Malhotra P., Amin K., Done A., Draghici S. Recent additions and improvements to the Onto-Tools. Nucleic Acids Res. 2005, 33:W762-W765.
38. Williams-Devane C.R., Wolf M.A., Richard A.M. Toward a public toxicogenomics capability for supporting predictive toxicology: survey of current resources and chemical indexing of experiments in GEO and ArrayExpress. Toxicol. Sci. 2009, 109:358-371.
39. Mattingly C.J., Rosenstein M.C., Colby G.T., Forrest J.N., Boyer J.L. The comparative toxicogenomics database (CTD): a resource for comparative toxicological studies. J. Exp. Zoolog. A Comp. Exp. Biol. 2006, 305:689-692.
40. Uehara T., Hirode M., Ono A., Kiyosawa N., Omura K., Shimizu T., Mizukawa Y., Miyagishima T., Nagao T., Urushidani T. A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats. Toxicology 2008, 250:15-26.
41. Castle A.L., Carver M.P., Mendrick D.L. Toxicogenomics: a new revolution in drug safety. Drug Discov. Today 2002, 7:728-736.
42. Waring J.F., Yang Y., Healan-Greenberg C.H., Adler A.L., Dickinson R., McNally T., Wang X., Weitzberg M., Xu X., Lisowski A., Warder S.E., Gu Y.G., Zinker B.A., Blomme E.A., Camp H.S. Gene expression analysis in rats treated with experimental acetyl-coenzyme A carboxylase inhibitors suggests interactions with the peroxisome proliferator-activated receptor alpha pathway. J. Pharmacol. Exp. Ther. 2008, 324:507-516.
43. Pappaert K., Vanderhoeven J., Desmet G., Van Hummelen P. Toward highly efficient automated hybridizations. Microarray innovations: technology and experimentation 2009, 71-86. CRC Press. G. Hardiman (Ed.).